News

MS Australia National Advocate Erin Brady reflects on International Day of People with Disability in a post-pandemic world.

Our Kiss Goodbye to MS ambassadors say thank you to the fantastic MS community by sharing their very own thank you letters.

MS researchers have investigated whether a naturally occurring molecule, which some DMTs mimic, has the capacity to promote myelin repair.

CEO Rohan Greenland gives an update on the MS Australia activities for November, focusing on MS Australia's 2021 Prime Award nomination.

New research funded by MS Australia has shown how UV light traps immune cells in the lymph nodes, similar to the action of some MS therapies.

MS Australia has funded seven new innovative MS research projects totalling nearly $150,000 in this year’s first round of incubator grants.

A study has followed the progress of over 500 people with MS who have undergone AHSCT for up to 5 years after the procedure.

MS Australia Chair of the John Studdy Award panel, Sharlene Brown, is delighted to announce the 2020 John Studdy Award winner is Mr Ian Pennell AM.

There have been recent positive steps forward for people with MS considering AHSCT. Read the current thinking towards AHSCT for people with MS.

CEO Rohan Greenland gives an update on the MS Australia activities for October, focusing on the world's largest MS research conference ECTRIMS and the importance of conferences in shaping the future of MS.

In 2015 Sarah's life changed completely when she was diagnosed with multiple sclerosis, she is now on a mission to raise funds to power MS research.

The International Progressive MS Alliance has recently highlighted that very little progress has been made in treating and understanding MS fatigue.

MS Australia's advocacy efforts have contributed to a number of subsidised MS medications and disease-modifying therapies (DMTs). New research now shows the effect this has on the outcomes for people living with MS in New Zealand.

As part of our advocacy work at MS Australia, we make many submissions each year, to various Australian Government inquiries and consultations.

MS Australia President, Associate Professor Desmond Graham has received University of Tasmania’s 2021 Award for Outstanding Contribution.

Over $6.7 million dollars will be invested into MS research by the National Health and Medical Research Council (NHMRC) in their funding scheme.

The Federal Health Minister has announced the listing of Kesimpta® (ofatumumab) on the PBS for the treatment of relapsing remitting MS.

His Excellency General the Honourable David Hurley AC DSC (Retd), the Governor-General of Australia, generously gifted a special medallion to MS Australia to award someone who has contributed to our work in significant way.